Skip to main content
C

Cessiononcology

Cession Oncology focuses on developing novel therapeutic approaches to combat aggressive and difficult-to-treat cancers. The company is advancing targeted treatments designed to overcome resistance mechanisms common in advanced malignancies. Their work aims to improve patient outcomes by addressing unmet needs in oncology care.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • Cession Oncology focuses on developing novel therapeutic approaches to address the most aggressive forms of cancer. The company is dedicated to advancing treatments that target hard-to-treat malignancies. Their work centers on creating new options for patients facing deadly cancer diagnoses.
This profile is AI-generated and may contain inaccuracies.